3i closes medical technology funding round

3i has added its 25th healthcare business to its portfolio after closing a financing round for Glucon, a US medical technology company.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.